Core Viewpoint - The successful listing of Jianfa Zhixin Medical Technology Group Co., Ltd. marks a significant milestone for the company and reflects the market's recognition of its focus on the medical device supply chain sector and innovation [1][2]. Group 1: Company Overview - Jianfa Zhixin is a key strategic subsidiary of Jianfa Group, focusing on the medical device supply chain, and has emerged as a leading player in this sector [1]. - The company aims to address industry pain points and challenges through innovation and digitalization, positioning itself as a top force in the national medical device supply chain service field [1]. Group 2: Leadership Statements - Wang Liangmu, Director of Xiamen State-owned Assets Supervision and Administration Commission, emphasized Jianfa Group's commitment to serving the real economy and social welfare, highlighting its consistent ranking in the Fortune Global 500 [1]. - Dong Haiming, Deputy Director of the Yangpu District People's Congress, noted that Jianfa Zhixin's successful listing is a recognition of its dedication to its core business and innovation, which will lead to new growth opportunities [2]. - Cheng Jie, Co-Director of CITIC Securities Investment Banking Committee, stated that the listing signifies a new level of collaboration between CITIC Securities and Jianfa Group, enhancing their partnership in various dimensions such as industry integration and investment services [2]. - Chairman Yu Feng expressed the company's commitment to leveraging the capital market to enhance service quality in health and life, focusing on industry challenges and actively contributing to social welfare [2].
建发致新9月25日登陆创业板 开启医疗器械供应链服务新篇章